专题：CNS Lymphoma Diagnosis and Treatment

This cluster of papers focuses on the diagnosis, treatment, and management of primary central nervous system lymphoma (PCNSL). It covers various aspects such as prognostic scoring systems, chemotherapy and radiotherapy regimens, use of methotrexate and rituximab therapy, genetic features, neurological masquerade syndromes, and cognitive functions in PCNSL patients.
最新文献
Case report: A case of intravascular large B-cell lymphoma and related literature review

article Full Text OpenAlex

Venetoclax in the Therapeutic Strategy for BPDCN Management

article Full Text OpenAlex

Primary central nervous system lymphomas in three “blue books” and correlation of recently defined primary large B-cell lymphoma of immune-privileged sites: Single-center experience

article Full Text OpenAlex

Clinicopathological Features and Pathogenesis of Thymoma Complicated with Alopecia Areata: A Multicenter, Matched Case Analysis

article Full Text OpenAlex

Rare vascular brain tumors: Gaps in evidence and unanswered questions

article Full Text OpenAlex

Epstein–Barr virus-associated focal cerebral arteriopathy in a child with stroke: a case report

article Full Text OpenAlex

Concomitant IV vancomycin causing delayed high-dose methotrexate clearance and acute kidney injury

article Full Text OpenAlex

Unexpected Diagnosis in a Cutaneous Tumoral Lesion: Primary Cutaneous Leg-Type B-Cell Lymphoma

article Full Text OpenAlex

The Pancytopenia Puzzle: Cracking the Case of Hidden Classical Hodgkin Lymphoma

article Full Text OpenAlex

Advanced T-cell Lymphoma with Penile Involvement Revealed by 18F-FDG PET/CT: A Rare Presentation

article Full Text OpenAlex

近5年高被引文献
Epidemiology of Non-Hodgkin’s Lymphoma

review Full Text OpenAlex 325 FWCI13.443

Pembrolizumab versus brentuximab vedotin in relapsed or refractory classical Hodgkin lymphoma (KEYNOTE-204): an interim analysis of a multicentre, randomised, open-label, phase 3 study

article Full Text OpenAlex 224 FWCI32.072

Brentuximab vedotin in combination with nivolumab in relapsed or refractory Hodgkin lymphoma: 3-year study results

article Full Text OpenAlex 174 FWCI26.027

Phase II Trial of Pembrolizumab Plus Gemcitabine, Vinorelbine, and Liposomal Doxorubicin as Second-Line Therapy for Relapsed or Refractory Classical Hodgkin Lymphoma

article Full Text OpenAlex 163 FWCI23.508

Primary central nervous system lymphoma

review Full Text OpenAlex 147 FWCI3.955

T-Cell Lymphomas, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology

article Full Text OpenAlex 135 FWCI23.94

Consensus recommendations for MRI and PET imaging of primary central nervous system lymphoma: guideline statement from the International Primary CNS Lymphoma Collaborative Group (IPCG)

article Full Text OpenAlex 131 FWCI13.81

SARS‐CoV‐2‐induced remission of Hodgkin lymphoma

article Full Text OpenAlex 130 FWCI20.654

Immune checkpoint inhibitor-related hearing loss: a systematic review and analysis of individual patient data

review Full Text OpenAlex 124 FWCI11.807

Long-term efficacy, safety and neurotolerability of MATRix regimen followed by autologous transplant in primary CNS lymphoma: 7-year results of the IELSG32 randomized trial

article Full Text OpenAlex 123 FWCI19.304